| | | | | | | |
 | CSL LIMITED | 0.24% | 1.81% | 3.10% | -5.63% | 9.62% | 97 491 |
 | SAMSUNG BIOLOGICS CO.,LTD. | 0.78% | 1.69% | 0.00% | 6.61% | 130.95% | 48 142 |
 | BIOGEN INC. | 0.56% | 0.75% | 27.19% | 22.00% | 0.84% | 43 942 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -1.65% | -7.55% | -48.41% | -54.13% | 63.15% | 25 777 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | -1.15% | -8.00% | -27.44% | -30.45% | 102.26% | 20 173 |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. | 0.47% | -4.80% | -1.52% | -12.88% | --.--% | 19 009 |
| BIOMARIN PHARMACEUTICAL INC. | -0.89% | 9.75% | 9.70% | 8.21% | 21.35% | 18 012 |
| WALVAX BIOTECHNOLOGY CO., LTD. | -1.50% | -5.56% | -22.88% | -35.61% | 40.40% | 9 666 |
| CELLTRION HEALTHCARE CO., LTD. | -2.12% | 0.15% | -19.33% | -21.44% | 40.24% | 7 517 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -0.90% | -2.56% | -30.88% | -36.62% | 25.04% | 7 202 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -4.03% | -18.12% | -46.64% | -34.36% | 21.37% | 7 018 |
 | GRIFOLS, S.A. | -0.67% | 6.22% | -38.76% | -41.44% | -66.37% | 6 609 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 0.74% | 2.44% | 17.77% | 0.93% | 37.19% | 6 187 |
| APELLIS PHARMACEUTICALS, INC. | 2.97% | 1.01% | 7.78% | 13.22% | 81.48% | 5 630 |
| INNOVENT BIOLOGICS, INC. | -2.95% | -13.71% | -41.97% | -62.52% | -2.10% | 5 489 |
| | | | | | | |
| | Gemiddelde | -0.67% | -2.43% | -14.15% | -18.94% | 36.10% | |
| | Gewogen gemiddelde per kap. | -0.16% | -0.59% | -4.29% | -8.90% | 40.85% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
